{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-169552","form_type":"8-K","ticker":null,"cik":"0001183765","company_name":"Molecular Templates, Inc.","filed_at":"2023-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.164270+00:00","generated_at":"2026-06-13T20:41:20.613621+00:00","sec_items":["1.01","1.02","2.03","2.05","3.02","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"MTEM restructures $37.8M K2HV debt with $27.5M cash, CVR, and warrants; cuts 44% workforce","bullets":["Paid $27.5M to settle $37.8M K2HV loan; remaining ~$10M converted to contingent value rights (CVR) with multipliers up to 2.5x.","K2HV received warrant to buy 5,103,343 shares at $0.3919, plus right to convert $3M of CVR into 6,124,011 shares.","Workforce reduced by ~44% (from 105 to ~46 employees) to extend cash runway while pursuing strategic alternatives.","Company exploring strategic alternatives with Stifel; no timeline set and no assurance of a completed transaction."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-169552","json":"https://secwatch.observer/filing/0001193125-23-169552.json","markdown":"https://secwatch.observer/filing/0001193125-23-169552.md","text":"https://secwatch.observer/filing/0001193125-23-169552.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1183765/000119312523169552/0001193125-23-169552-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1183765/000119312523169552/d512399d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T20:41:20.613621+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"90b9db2e853597feb4a858a39ea8839f6cf929fa","claim":"Molecular Templates, Inc. incurred debt of Remaining Value which is initially $10,303,646 with K2 HealthVentures LLC.","evidence_excerpt":"The payment due upon any Contingent Payment Event or an Acceleration Event is capped at an amount (the “Remaining Value”) which is initially $10,303,646","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1183765/000119312523169552/0001193125-23-169552-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Principal","value":"Remaining Value which is initially $10,303,646"},{"label":"Counterparty","value":"K2 HealthVentures LLC"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}